WHO Calls On Countries To Scale Up Hepatitis Services, Invest In Elimination 29/07/2019 David Branigan 80 percent of people with viral hepatitis lack access to services for prevention, testing & treatment. To address this gap, the World Health Organization calls on countries to invest in scaling up hepatitis services as part of their universal health coverage (UHC) plans. On the occasion of World Hepatitis Day (28 July), WHO raised alarm […] Continue reading -> US Pick For UN Ambassador Disputes Sexual & Reproductive Rights, Draws Opposition 23/07/2019 David Branigan A United States congressional committee met today to vote on whether or not to recommend Andrew Bremberg for confirmation as Ambassador to the United Nations in Geneva. Bremberg is a controversial pick due to his extreme stance against abortion and his pledge to vote against any UN resolution that includes the right to abortion where […] Continue reading -> New HIV Infections Declining, But So Is Funding To Combat The Disease 16/07/2019 David Branigan A new UNAIDS report found that while new HIV infections have declined globally since 2010, the rate of progress has slowed, with some regions showing increases in new infections. Available resources for HIV have also dropped by US$ 1 billion in 2018, marking the first time global HIV funding declined since 2000. UNAIDS’ Global AIDS […] Continue reading -> Who should lead UNAIDS? 05/07/2019 Guest contributor [Republished from The Lancet] Richard Horton, Editor-in-Chief of The Lancet, examines the issues around the pending appointment of a new executive director for UNAIDS, as well as the candidates for the post, following the May resignation of executive director Michel Sidibé. The selection process has fueled questions about who may now be best positioned to […] Continue reading -> No Significant Difference In HIV Risk Among Users Of Hormonal Or IUD Contraception 13/06/2019 Editorial team In what should prove reassuring to many women, a large clinical study in four African countries has found no significant difference in the risk of HIV infection among women using progestogen-based hormones or copper-bearing IUDs as contraception. However with “unacceptably high” rates of HIV infection among users of both contraceptive modes during the study, adoption […] Continue reading -> UNAIDS welcomes the decision of the High Court of Botswana to repeal laws that criminalize and discriminate against LGBT people 11/06/2019 Editorial team [UNAIDS Press Release] GENEVA, 11 June 2019— UNAIDS applauds the landmark decision of the High Court of Botswana to declare unconstitutional key provisions of Sections 164 and 167 of the Botswana Penal Code. Those provisions criminalized certain private sexual acts and have led to discrimination and violence against lesbian, gay, bisexual and transgender (LGBT) people in […] Continue reading -> Curable STI Rates Show No Sign Of Declining – Most People Infected Don’t Know 06/06/2019 David Branigan 1 in 25 people globally have at least one of the four major preventable and curable sexually transmitted infections (STIs) – chlamydia, gonorrhoea, trichomoniasis, and syphilis – but most people don’t know they are infected, leading to serious health consequences. Image Credits: Jonathan Torgovnik/WHO. Continue reading -> Negotiators Agree On Game-Changing WHA Resolution For Medicine Price Disclosure 27/05/2019 Catherine Saez A closed-door group of negotiators reached agreement late Monday evening on a game-changing resolution to support greater public disclosure of prices in medicine markets, as well as costs of related R&D investments. Image Credits: Catherine Saez, WHO. Continue reading -> Medicine Prices: Secrecy Of R&D Costs Remains Issue In Near-Final World Health Assembly Resolution 26/05/2019 Elaine Ruth Fletcher The latest working draft World Health Assembly resolution calling for game-changing public disclosure of the prices paid for medicines, vaccines and other health products by countries and health systems shows a broad coalition of countries from Europe, Latin America, Africa and Asia forming around the compromise draft. The draft, obtained Sunday by Health Policy Watch, […] Continue reading -> Medicine Prices – Delegates Near Agreement On Softer Resolution For Disclosure 26/05/2019 Elaine Ruth Fletcher After a grueling 34 hours of nearly non-stop negotiations, World Health Assembly delegates appeared to be close to a final agreement Saturday evening on a resolution supporting more systematic disclosure of prices for medicines purchased and sold on national and global markets; a “drafting group” is expected to reconvene Monday morning to put the finishing […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
US Pick For UN Ambassador Disputes Sexual & Reproductive Rights, Draws Opposition 23/07/2019 David Branigan A United States congressional committee met today to vote on whether or not to recommend Andrew Bremberg for confirmation as Ambassador to the United Nations in Geneva. Bremberg is a controversial pick due to his extreme stance against abortion and his pledge to vote against any UN resolution that includes the right to abortion where […] Continue reading -> New HIV Infections Declining, But So Is Funding To Combat The Disease 16/07/2019 David Branigan A new UNAIDS report found that while new HIV infections have declined globally since 2010, the rate of progress has slowed, with some regions showing increases in new infections. Available resources for HIV have also dropped by US$ 1 billion in 2018, marking the first time global HIV funding declined since 2000. UNAIDS’ Global AIDS […] Continue reading -> Who should lead UNAIDS? 05/07/2019 Guest contributor [Republished from The Lancet] Richard Horton, Editor-in-Chief of The Lancet, examines the issues around the pending appointment of a new executive director for UNAIDS, as well as the candidates for the post, following the May resignation of executive director Michel Sidibé. The selection process has fueled questions about who may now be best positioned to […] Continue reading -> No Significant Difference In HIV Risk Among Users Of Hormonal Or IUD Contraception 13/06/2019 Editorial team In what should prove reassuring to many women, a large clinical study in four African countries has found no significant difference in the risk of HIV infection among women using progestogen-based hormones or copper-bearing IUDs as contraception. However with “unacceptably high” rates of HIV infection among users of both contraceptive modes during the study, adoption […] Continue reading -> UNAIDS welcomes the decision of the High Court of Botswana to repeal laws that criminalize and discriminate against LGBT people 11/06/2019 Editorial team [UNAIDS Press Release] GENEVA, 11 June 2019— UNAIDS applauds the landmark decision of the High Court of Botswana to declare unconstitutional key provisions of Sections 164 and 167 of the Botswana Penal Code. Those provisions criminalized certain private sexual acts and have led to discrimination and violence against lesbian, gay, bisexual and transgender (LGBT) people in […] Continue reading -> Curable STI Rates Show No Sign Of Declining – Most People Infected Don’t Know 06/06/2019 David Branigan 1 in 25 people globally have at least one of the four major preventable and curable sexually transmitted infections (STIs) – chlamydia, gonorrhoea, trichomoniasis, and syphilis – but most people don’t know they are infected, leading to serious health consequences. Image Credits: Jonathan Torgovnik/WHO. Continue reading -> Negotiators Agree On Game-Changing WHA Resolution For Medicine Price Disclosure 27/05/2019 Catherine Saez A closed-door group of negotiators reached agreement late Monday evening on a game-changing resolution to support greater public disclosure of prices in medicine markets, as well as costs of related R&D investments. Image Credits: Catherine Saez, WHO. Continue reading -> Medicine Prices: Secrecy Of R&D Costs Remains Issue In Near-Final World Health Assembly Resolution 26/05/2019 Elaine Ruth Fletcher The latest working draft World Health Assembly resolution calling for game-changing public disclosure of the prices paid for medicines, vaccines and other health products by countries and health systems shows a broad coalition of countries from Europe, Latin America, Africa and Asia forming around the compromise draft. The draft, obtained Sunday by Health Policy Watch, […] Continue reading -> Medicine Prices – Delegates Near Agreement On Softer Resolution For Disclosure 26/05/2019 Elaine Ruth Fletcher After a grueling 34 hours of nearly non-stop negotiations, World Health Assembly delegates appeared to be close to a final agreement Saturday evening on a resolution supporting more systematic disclosure of prices for medicines purchased and sold on national and global markets; a “drafting group” is expected to reconvene Monday morning to put the finishing […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
New HIV Infections Declining, But So Is Funding To Combat The Disease 16/07/2019 David Branigan A new UNAIDS report found that while new HIV infections have declined globally since 2010, the rate of progress has slowed, with some regions showing increases in new infections. Available resources for HIV have also dropped by US$ 1 billion in 2018, marking the first time global HIV funding declined since 2000. UNAIDS’ Global AIDS […] Continue reading -> Who should lead UNAIDS? 05/07/2019 Guest contributor [Republished from The Lancet] Richard Horton, Editor-in-Chief of The Lancet, examines the issues around the pending appointment of a new executive director for UNAIDS, as well as the candidates for the post, following the May resignation of executive director Michel Sidibé. The selection process has fueled questions about who may now be best positioned to […] Continue reading -> No Significant Difference In HIV Risk Among Users Of Hormonal Or IUD Contraception 13/06/2019 Editorial team In what should prove reassuring to many women, a large clinical study in four African countries has found no significant difference in the risk of HIV infection among women using progestogen-based hormones or copper-bearing IUDs as contraception. However with “unacceptably high” rates of HIV infection among users of both contraceptive modes during the study, adoption […] Continue reading -> UNAIDS welcomes the decision of the High Court of Botswana to repeal laws that criminalize and discriminate against LGBT people 11/06/2019 Editorial team [UNAIDS Press Release] GENEVA, 11 June 2019— UNAIDS applauds the landmark decision of the High Court of Botswana to declare unconstitutional key provisions of Sections 164 and 167 of the Botswana Penal Code. Those provisions criminalized certain private sexual acts and have led to discrimination and violence against lesbian, gay, bisexual and transgender (LGBT) people in […] Continue reading -> Curable STI Rates Show No Sign Of Declining – Most People Infected Don’t Know 06/06/2019 David Branigan 1 in 25 people globally have at least one of the four major preventable and curable sexually transmitted infections (STIs) – chlamydia, gonorrhoea, trichomoniasis, and syphilis – but most people don’t know they are infected, leading to serious health consequences. Image Credits: Jonathan Torgovnik/WHO. Continue reading -> Negotiators Agree On Game-Changing WHA Resolution For Medicine Price Disclosure 27/05/2019 Catherine Saez A closed-door group of negotiators reached agreement late Monday evening on a game-changing resolution to support greater public disclosure of prices in medicine markets, as well as costs of related R&D investments. Image Credits: Catherine Saez, WHO. Continue reading -> Medicine Prices: Secrecy Of R&D Costs Remains Issue In Near-Final World Health Assembly Resolution 26/05/2019 Elaine Ruth Fletcher The latest working draft World Health Assembly resolution calling for game-changing public disclosure of the prices paid for medicines, vaccines and other health products by countries and health systems shows a broad coalition of countries from Europe, Latin America, Africa and Asia forming around the compromise draft. The draft, obtained Sunday by Health Policy Watch, […] Continue reading -> Medicine Prices – Delegates Near Agreement On Softer Resolution For Disclosure 26/05/2019 Elaine Ruth Fletcher After a grueling 34 hours of nearly non-stop negotiations, World Health Assembly delegates appeared to be close to a final agreement Saturday evening on a resolution supporting more systematic disclosure of prices for medicines purchased and sold on national and global markets; a “drafting group” is expected to reconvene Monday morning to put the finishing […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Who should lead UNAIDS? 05/07/2019 Guest contributor [Republished from The Lancet] Richard Horton, Editor-in-Chief of The Lancet, examines the issues around the pending appointment of a new executive director for UNAIDS, as well as the candidates for the post, following the May resignation of executive director Michel Sidibé. The selection process has fueled questions about who may now be best positioned to […] Continue reading -> No Significant Difference In HIV Risk Among Users Of Hormonal Or IUD Contraception 13/06/2019 Editorial team In what should prove reassuring to many women, a large clinical study in four African countries has found no significant difference in the risk of HIV infection among women using progestogen-based hormones or copper-bearing IUDs as contraception. However with “unacceptably high” rates of HIV infection among users of both contraceptive modes during the study, adoption […] Continue reading -> UNAIDS welcomes the decision of the High Court of Botswana to repeal laws that criminalize and discriminate against LGBT people 11/06/2019 Editorial team [UNAIDS Press Release] GENEVA, 11 June 2019— UNAIDS applauds the landmark decision of the High Court of Botswana to declare unconstitutional key provisions of Sections 164 and 167 of the Botswana Penal Code. Those provisions criminalized certain private sexual acts and have led to discrimination and violence against lesbian, gay, bisexual and transgender (LGBT) people in […] Continue reading -> Curable STI Rates Show No Sign Of Declining – Most People Infected Don’t Know 06/06/2019 David Branigan 1 in 25 people globally have at least one of the four major preventable and curable sexually transmitted infections (STIs) – chlamydia, gonorrhoea, trichomoniasis, and syphilis – but most people don’t know they are infected, leading to serious health consequences. Image Credits: Jonathan Torgovnik/WHO. Continue reading -> Negotiators Agree On Game-Changing WHA Resolution For Medicine Price Disclosure 27/05/2019 Catherine Saez A closed-door group of negotiators reached agreement late Monday evening on a game-changing resolution to support greater public disclosure of prices in medicine markets, as well as costs of related R&D investments. Image Credits: Catherine Saez, WHO. Continue reading -> Medicine Prices: Secrecy Of R&D Costs Remains Issue In Near-Final World Health Assembly Resolution 26/05/2019 Elaine Ruth Fletcher The latest working draft World Health Assembly resolution calling for game-changing public disclosure of the prices paid for medicines, vaccines and other health products by countries and health systems shows a broad coalition of countries from Europe, Latin America, Africa and Asia forming around the compromise draft. The draft, obtained Sunday by Health Policy Watch, […] Continue reading -> Medicine Prices – Delegates Near Agreement On Softer Resolution For Disclosure 26/05/2019 Elaine Ruth Fletcher After a grueling 34 hours of nearly non-stop negotiations, World Health Assembly delegates appeared to be close to a final agreement Saturday evening on a resolution supporting more systematic disclosure of prices for medicines purchased and sold on national and global markets; a “drafting group” is expected to reconvene Monday morning to put the finishing […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
No Significant Difference In HIV Risk Among Users Of Hormonal Or IUD Contraception 13/06/2019 Editorial team In what should prove reassuring to many women, a large clinical study in four African countries has found no significant difference in the risk of HIV infection among women using progestogen-based hormones or copper-bearing IUDs as contraception. However with “unacceptably high” rates of HIV infection among users of both contraceptive modes during the study, adoption […] Continue reading -> UNAIDS welcomes the decision of the High Court of Botswana to repeal laws that criminalize and discriminate against LGBT people 11/06/2019 Editorial team [UNAIDS Press Release] GENEVA, 11 June 2019— UNAIDS applauds the landmark decision of the High Court of Botswana to declare unconstitutional key provisions of Sections 164 and 167 of the Botswana Penal Code. Those provisions criminalized certain private sexual acts and have led to discrimination and violence against lesbian, gay, bisexual and transgender (LGBT) people in […] Continue reading -> Curable STI Rates Show No Sign Of Declining – Most People Infected Don’t Know 06/06/2019 David Branigan 1 in 25 people globally have at least one of the four major preventable and curable sexually transmitted infections (STIs) – chlamydia, gonorrhoea, trichomoniasis, and syphilis – but most people don’t know they are infected, leading to serious health consequences. Image Credits: Jonathan Torgovnik/WHO. Continue reading -> Negotiators Agree On Game-Changing WHA Resolution For Medicine Price Disclosure 27/05/2019 Catherine Saez A closed-door group of negotiators reached agreement late Monday evening on a game-changing resolution to support greater public disclosure of prices in medicine markets, as well as costs of related R&D investments. Image Credits: Catherine Saez, WHO. Continue reading -> Medicine Prices: Secrecy Of R&D Costs Remains Issue In Near-Final World Health Assembly Resolution 26/05/2019 Elaine Ruth Fletcher The latest working draft World Health Assembly resolution calling for game-changing public disclosure of the prices paid for medicines, vaccines and other health products by countries and health systems shows a broad coalition of countries from Europe, Latin America, Africa and Asia forming around the compromise draft. The draft, obtained Sunday by Health Policy Watch, […] Continue reading -> Medicine Prices – Delegates Near Agreement On Softer Resolution For Disclosure 26/05/2019 Elaine Ruth Fletcher After a grueling 34 hours of nearly non-stop negotiations, World Health Assembly delegates appeared to be close to a final agreement Saturday evening on a resolution supporting more systematic disclosure of prices for medicines purchased and sold on national and global markets; a “drafting group” is expected to reconvene Monday morning to put the finishing […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
UNAIDS welcomes the decision of the High Court of Botswana to repeal laws that criminalize and discriminate against LGBT people 11/06/2019 Editorial team [UNAIDS Press Release] GENEVA, 11 June 2019— UNAIDS applauds the landmark decision of the High Court of Botswana to declare unconstitutional key provisions of Sections 164 and 167 of the Botswana Penal Code. Those provisions criminalized certain private sexual acts and have led to discrimination and violence against lesbian, gay, bisexual and transgender (LGBT) people in […] Continue reading -> Curable STI Rates Show No Sign Of Declining – Most People Infected Don’t Know 06/06/2019 David Branigan 1 in 25 people globally have at least one of the four major preventable and curable sexually transmitted infections (STIs) – chlamydia, gonorrhoea, trichomoniasis, and syphilis – but most people don’t know they are infected, leading to serious health consequences. Image Credits: Jonathan Torgovnik/WHO. Continue reading -> Negotiators Agree On Game-Changing WHA Resolution For Medicine Price Disclosure 27/05/2019 Catherine Saez A closed-door group of negotiators reached agreement late Monday evening on a game-changing resolution to support greater public disclosure of prices in medicine markets, as well as costs of related R&D investments. Image Credits: Catherine Saez, WHO. Continue reading -> Medicine Prices: Secrecy Of R&D Costs Remains Issue In Near-Final World Health Assembly Resolution 26/05/2019 Elaine Ruth Fletcher The latest working draft World Health Assembly resolution calling for game-changing public disclosure of the prices paid for medicines, vaccines and other health products by countries and health systems shows a broad coalition of countries from Europe, Latin America, Africa and Asia forming around the compromise draft. The draft, obtained Sunday by Health Policy Watch, […] Continue reading -> Medicine Prices – Delegates Near Agreement On Softer Resolution For Disclosure 26/05/2019 Elaine Ruth Fletcher After a grueling 34 hours of nearly non-stop negotiations, World Health Assembly delegates appeared to be close to a final agreement Saturday evening on a resolution supporting more systematic disclosure of prices for medicines purchased and sold on national and global markets; a “drafting group” is expected to reconvene Monday morning to put the finishing […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Curable STI Rates Show No Sign Of Declining – Most People Infected Don’t Know 06/06/2019 David Branigan 1 in 25 people globally have at least one of the four major preventable and curable sexually transmitted infections (STIs) – chlamydia, gonorrhoea, trichomoniasis, and syphilis – but most people don’t know they are infected, leading to serious health consequences. Image Credits: Jonathan Torgovnik/WHO. Continue reading -> Negotiators Agree On Game-Changing WHA Resolution For Medicine Price Disclosure 27/05/2019 Catherine Saez A closed-door group of negotiators reached agreement late Monday evening on a game-changing resolution to support greater public disclosure of prices in medicine markets, as well as costs of related R&D investments. Image Credits: Catherine Saez, WHO. Continue reading -> Medicine Prices: Secrecy Of R&D Costs Remains Issue In Near-Final World Health Assembly Resolution 26/05/2019 Elaine Ruth Fletcher The latest working draft World Health Assembly resolution calling for game-changing public disclosure of the prices paid for medicines, vaccines and other health products by countries and health systems shows a broad coalition of countries from Europe, Latin America, Africa and Asia forming around the compromise draft. The draft, obtained Sunday by Health Policy Watch, […] Continue reading -> Medicine Prices – Delegates Near Agreement On Softer Resolution For Disclosure 26/05/2019 Elaine Ruth Fletcher After a grueling 34 hours of nearly non-stop negotiations, World Health Assembly delegates appeared to be close to a final agreement Saturday evening on a resolution supporting more systematic disclosure of prices for medicines purchased and sold on national and global markets; a “drafting group” is expected to reconvene Monday morning to put the finishing […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Negotiators Agree On Game-Changing WHA Resolution For Medicine Price Disclosure 27/05/2019 Catherine Saez A closed-door group of negotiators reached agreement late Monday evening on a game-changing resolution to support greater public disclosure of prices in medicine markets, as well as costs of related R&D investments. Image Credits: Catherine Saez, WHO. Continue reading -> Medicine Prices: Secrecy Of R&D Costs Remains Issue In Near-Final World Health Assembly Resolution 26/05/2019 Elaine Ruth Fletcher The latest working draft World Health Assembly resolution calling for game-changing public disclosure of the prices paid for medicines, vaccines and other health products by countries and health systems shows a broad coalition of countries from Europe, Latin America, Africa and Asia forming around the compromise draft. The draft, obtained Sunday by Health Policy Watch, […] Continue reading -> Medicine Prices – Delegates Near Agreement On Softer Resolution For Disclosure 26/05/2019 Elaine Ruth Fletcher After a grueling 34 hours of nearly non-stop negotiations, World Health Assembly delegates appeared to be close to a final agreement Saturday evening on a resolution supporting more systematic disclosure of prices for medicines purchased and sold on national and global markets; a “drafting group” is expected to reconvene Monday morning to put the finishing […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Medicine Prices: Secrecy Of R&D Costs Remains Issue In Near-Final World Health Assembly Resolution 26/05/2019 Elaine Ruth Fletcher The latest working draft World Health Assembly resolution calling for game-changing public disclosure of the prices paid for medicines, vaccines and other health products by countries and health systems shows a broad coalition of countries from Europe, Latin America, Africa and Asia forming around the compromise draft. The draft, obtained Sunday by Health Policy Watch, […] Continue reading -> Medicine Prices – Delegates Near Agreement On Softer Resolution For Disclosure 26/05/2019 Elaine Ruth Fletcher After a grueling 34 hours of nearly non-stop negotiations, World Health Assembly delegates appeared to be close to a final agreement Saturday evening on a resolution supporting more systematic disclosure of prices for medicines purchased and sold on national and global markets; a “drafting group” is expected to reconvene Monday morning to put the finishing […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Medicine Prices – Delegates Near Agreement On Softer Resolution For Disclosure 26/05/2019 Elaine Ruth Fletcher After a grueling 34 hours of nearly non-stop negotiations, World Health Assembly delegates appeared to be close to a final agreement Saturday evening on a resolution supporting more systematic disclosure of prices for medicines purchased and sold on national and global markets; a “drafting group” is expected to reconvene Monday morning to put the finishing […] Continue reading -> Posts navigation Older postsNewer posts